Catalyst Pharmaceuticals, Inc.

352 articles about Catalyst Pharmaceuticals, Inc.

• Catalyst Pharmaceutical Partners Reports First Quarter 2007 Financial Results

  5/15/2007

• Catalyst Pharmaceutical Partners Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's Investigational Drug to Treat Cocaine and Methamphetamine Addiction

  5/9/2007

• Catalyst Pharmaceutical Partners Names Vice President of Pharmaceutical Development and Project Management

  4/4/2007

• Catalyst Pharmaceutical Partners Reports Year-End 2006 Financial Results

  4/3/2007

• Catalyst Pharmaceutical Partners Strengthens Scientific Advisory Board With Appointment Of Richard A. Rawson, Ph.D.

  2/14/2007

• Catalyst Pharmaceutical Partners Adds Thomas Kosten, M.D. To Its Scientific Advisory Board

  1/12/2007

• Catalyst Pharmaceutical Partners Trial Delayed

  1/3/2007

• Catalyst Pharmaceutical Partners Announces Results Of Operations For 2006 Third Quarter

  12/18/2006

• Catalyst Pharmaceutical Partners Announces Closing Of Initial Public Offering

  11/14/2006

• IPO Watch: Is Catalyst Pharmaceutical Partners A Bargain At Half The Price?

  11/10/2006

• The Day In Review: News From The Hepatitis Front

  10/27/2006

• Catalyst Pharmaceutical Partners Appoints Chief Medical Officer And Vice President Of Regulatory Operations

  9/7/2006